What is the FEI / inspection ID for this Form 483?

FEI / inspection ID: 3021621451.

Is a Form 483 the same as a Warning Letter?

No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.

Where can I read the full Form 483?

The verbatim inspection record is the source of truth — always confirm citation language against the original FDA document before acting.

What is an FDA Form 483?

A Form FDA 483 lists an FDA investigator's written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.

Form 483 Record: Isorx Cyclotron Center, March 13, 2026

Here's the summary: FDA inspected Isorx Cyclotron Center in Texas, USA and issued a Form 483 listing 1 inspectional observation following an inspection that concluded 2026-03-13. FDA records classify Isorx Cyclotron Center as a drug manufacturer. A Form 483 documents an investigator's findings at the close of an inspection under the Federal Food, Drug, and Cosmetic Act; it is not a final agency compliance determination. The observations on this page are drawn directly from the FDA-issued Form 483 record.

Key facts

Firm	Isorx Cyclotron Center
FEI / inspection ID	3021621451
Inspection end date	March 13, 2026
Citation count	1

Citations explained

Observation 1 — -- 1 of 11 -- -- 2 of 11 -- -- 3

-- 1 of 11 -- -- 2 of 11 -- -- 3 of 11 -- -- 4 of 11 -- -- 5 of 11 -- -- 6 of 11 -- -- 7 of 11 -- -- 8 of 11 -- -- 9 of 11 -- -- 10 of 11 -- The observations of objectionable conditions and practices listed on the front of this form are reported: 1. Pursuant to Section 704(b) of the Federal Food, Drug and Cosmetic Act, or 2. To assist firms inspected in complying with the Acts and regulations enforced by the Food and Drug Administration. Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21 USC 374(b)) provides: "Upon completion of any such inspection of a factory, warehouse, consulting laboratory, or other establishment, and prior to leaving the premises, the officer or employee making the inspection shall give to the owner, operator, or agent in charge a report in writing setting forth any conditions or.

What a Form 483 means

A Form FDA 483 is issued at the close of an FDA facility inspection to list conditions an investigator observed that may violate the Federal Food, Drug, and Cosmetic Act or its implementing regulations. It reflects the investigator's professional judgment at that point in time and is not a final agency determination, an enforcement action, or proof that a violation occurred. Firms are expected to respond in writing, typically within 15 business days, describing the corrective and preventive actions they plan to take. FDA reviews that response, along with any follow-up evidence, before deciding what happens next. Many 483s are resolved through corrective action alone. When FDA judges a firm's response inadequate, or when the underlying conditions are serious enough, the observations documented here can lead to a Warning Letter or further regulatory action. This page presents the observations exactly as recorded on the FDA-issued document; always confirm citation language against the original record before relying on it.

Isorx Cyclotron Center’s FDA history

Argus HQ has recorded 1 total FDA action tied to Isorx Cyclotron Center: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

Frequently asked questions

What is the FEI / inspection ID for this Form 483?: FEI / inspection ID: 3021621451.
Is a Form 483 the same as a Warning Letter?: No. A Form 483 lists an FDA investigator’s observations at the close of an inspection; it is not a final agency determination. FDA may or may not follow up with a Warning Letter depending on the firm’s response and the severity of the findings.
Where can I read the full Form 483?: The verbatim inspection record is the source of truth — always confirm citation language against the original FDA document before acting.
What is an FDA Form 483?: A Form FDA 483 lists an FDA investigator's written observations at the close of a facility inspection, issued under section 704(b) of the Federal Food, Drug, and Cosmetic Act. It documents conditions the investigator judged may violate FDA regulations. A 483 is not an enforcement action or a final determination that a violation occurred.

See if this 483 escalates to a warning letter — before your auditor asks.

Free weekly briefing tracks every FDA inspection outcome.

Full FDA history for Isorx Cyclotron Center

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). Form 483 Record: Isorx Cyclotron Center, March 13, 2026 — 1 Citations. Digital Empire LLC. Retrieved from https://argushq.ai/483/fda-483-isorx-cyclotron-center-2026-03-13-3021621451

MLA

"Form 483 Record: Isorx Cyclotron Center, March 13, 2026 — 1 Citations." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/483/fda-483-isorx-cyclotron-center-2026-03-13-3021621451.

Chicago

Argus HQ Research. "Form 483 Record: Isorx Cyclotron Center, March 13, 2026 — 1 Citations." Digital Empire LLC. Accessed July 13, 2026. https://argushq.ai/483/fda-483-isorx-cyclotron-center-2026-03-13-3021621451.

BibTeX

@misc{argushq_argushq_ai_483_fda_483_isorx_cyclotron_center_2026_03_13_3021621451_2026,
  title = {Form 483 Record: Isorx Cyclotron Center, March 13, 2026 — 1 Citations},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/483/fda-483-isorx-cyclotron-center-2026-03-13-3021621451},
  note = {Accessed: July 13, 2026}
}

Source: FDA.gov — Inspection Classification Database ↗